A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
Clinical trial NCT05334719 · COMPLETED
Trial details
- NCT number
- NCT05334719
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-29
- Primary completion
- 2026-01-16
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.